These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6388328)
1. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension. Williams RL; Clark T; Blume CD Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328 [TBL] [Abstract][Full Text] [Related]
2. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide). Blume CD; Williams RL Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide. Casner PR; Dillon KR J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product. Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698 [TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension. Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension. Schnaper HW; Maxwell MH Am J Cardiol; 1989 Jan; 63(4):32B-36B. PubMed ID: 2643290 [TBL] [Abstract][Full Text] [Related]
7. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly. Woo J; Woo KS; Kin T; Vallance-Owen J Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion. Zawada ET Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial. Maroko PR; McDevitt JT; Fox MJ; Silber SA; Young MD; Beg M; Rockhold FW; Free SM; Herron JR; Gray JM Clin Ther; 1989; 11(1):94-119. PubMed ID: 2655909 [TBL] [Abstract][Full Text] [Related]
10. Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide. Davidov ME; Becker FE; Hollifield JW Am J Med; 1987 Mar; 82(3A):48-51. PubMed ID: 3565425 [TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide and triamterene with sustained-release oxprenolol in the treatment of hypertension. Backhouse CI; Rowley-Jones D; Spencer-Mills L Curr Med Res Opin; 1986; 10(3):196-202. PubMed ID: 3731824 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE). Amery A; Berthaux P; Birkenhäger W; Boel A; Brixko P; Bulpitt C; Clement D; Deruyttere M; de Schaepdryver A; Dollery C; Fagard R; Forette F; Henry JF; Hellemans J; Laaser U; Lund-Johansen P; MacFarlane J; Maling T; Mutsers A; Nissinen A; Ohn OH; Pelemans J; Suchettkaye AI; Tuomilehto J; Willems J Acta Cardiol; 1978; 33(2):113-34. PubMed ID: 356497 [TBL] [Abstract][Full Text] [Related]
13. The short-term effects of reducing elevated blood pressure in elderly patients with propranolol and dyazide. Hamdy RC; Davies A; Arnold K; Tovey JD; Saimbi SS; Short MD; Exton-Smith AN Age Ageing; 1984 Mar; 13(2):83-8. PubMed ID: 6731169 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide. Blume CD; Williams RL; Upton RA; Lin ET; Benet LZ Am J Med; 1984 Nov; 77(5A):59-61. PubMed ID: 6496560 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of a fixed-dose combination of antihypertensive agents: an open-label surveillance study in China. Wu Y; Hu Y; Tang X; He L; Ren T; Tao Q; Qin X; Sun N; Wang H; Cao W; Wu T; Zhan S; Wang J; Chen W; Li L Clin Drug Investig; 2011 Nov; 31(11):769-77. PubMed ID: 21671689 [TBL] [Abstract][Full Text] [Related]
16. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly. Woo J; Woo KS; Vallance-Owen J Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357 [No Abstract] [Full Text] [Related]
17. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene. Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363 [TBL] [Abstract][Full Text] [Related]
18. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure. Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153 [TBL] [Abstract][Full Text] [Related]
19. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide). Hollenberg NK; Mickiewicz CW Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994 [TBL] [Abstract][Full Text] [Related]
20. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination. Douglas JG; Hollifield JW; Liddle GW JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187 [No Abstract] [Full Text] [Related] [Next] [New Search]